The (I²SysBio) in Valencia, Spain is recruiting a highly motivated doctoral student to join its internationally recognised research team working on virus-host interactions and antiviral immunity.
Researchers with a passion for virology, molecular biology, and infectious disease research have an exciting opportunity to pursue a fully funded PhD in Spain.
The position is funded through Spain’s prestigious FPI (Formación de Personal Investigador) doctoral programme and is linked to the research project “Host Factors Inhibiting Viral Entry: Discovery and Mechanistic Profiling (H5:DaMP)”, led by Principal Investigator Dr. Jérémy Dufloo.
The project is funded by the Spanish Ministry of Science, Innovation and Universities and offers four years of fully funded doctoral research, international collaboration opportunities, and advanced scientific training.
The doctoral position is hosted at the Institute for Integrative Systems Biology (I²SysBio), a joint research institute of the University of Valencia and the Spanish National Research Council (CSIC) in Valencia, Spain.
The successful candidate will become part of an international and multidisciplinary laboratory investigating how viruses invade host cells and how human antiviral proteins can block viral infections. The project combines cutting-edge experimental and computational approaches to better understand viral entry mechanisms across numerous virus families.
The PhD candidate will also enrol in the University of Valencia Doctoral Programme in Biomedicine and Biotechnology, gaining access to extensive scientific and transferable skills training throughout the programme.
Viruses must successfully enter host cells before they can replicate, making viral entry one of the most critical stages of infection. Despite significant advances in virology, many host proteins capable of preventing viral entry remain unidentified, and the mechanisms through which they function are still poorly understood.
This research project aims to discover and characterize these antiviral restriction factors using a combination of innovative laboratory and computational techniques.
The project will utilise:
One of the project’s unique strengths is its extensive collection of more than 100 viral pseudotypes representing 14 different virus families, allowing researchers to systematically investigate viral entry inhibition across a wide range of emerging human and animal viruses.
The findings are expected to contribute significantly to the understanding of antiviral immunity and may support the development of future antiviral therapies.

The selected doctoral researcher will receive a comprehensive funding package under Spain’s highly competitive FPI doctoral programme.
Benefits include:
The programme provides an excellent platform for students seeking careers in academic research, biotechnology, biomedical sciences, or the pharmaceutical industry.
During the doctoral programme, the successful candidate will receive multidisciplinary training across several advanced scientific fields, including:
Working within a collaborative international research environment will allow the student to develop both technical expertise and independent research skills.
The research group is seeking highly motivated candidates with strong academic backgrounds in life sciences.
Applicants should:
The laboratory welcomes applicants from diverse scientific backgrounds who are enthusiastic about pursuing cutting-edge biomedical research.
Previous laboratory experience is considered an advantage but is not mandatory.
Experience in any of the following areas will strengthen an application:
Candidates without experience in every area are still encouraged to apply if they demonstrate strong academic potential and motivation.
This PhD offers much more than financial support. It provides an opportunity to join one of Spain’s leading research environments while working on globally important questions in infectious disease biology.
Successful applicants will benefit from:
The interdisciplinary nature of the programme also prepares graduates for careers across academia, research institutes, biotechnology companies, public health, and pharmaceutical industries.
Interested applicants should prepare the following documents:
Applicants should ensure that their motivation letter clearly explains their research interests, academic background, and reasons for applying to the programme.
Applications should be submitted directly by email to the Principal Investigator:
Dr. Jérémy Dufloo
Applicants should email their complete application package, including the motivation letter, CV, and referee contact details.
Early applications are encouraged as recruitment may continue until a suitable candidate is identified.
SEE ATTACHED IMAGE TO APPLY
For graduates seeking a fully funded PhD in virology, molecular biology, or biomedical sciences, this opportunity at the Institute for Integrative Systems Biology offers an outstanding chance to contribute to internationally significant research while developing advanced scientific expertise in one of Europe’s leading research environments.
Disclaimer: Global South Opportunities (GSO) is not the organization offering this opportunity. For any inquiries, please contact the official organization directly. Please do not send your applications & CVs to GSO, as we are unable to process them. Due to the high volume of emails, we receive daily, we may not be able to respond to all inquiries. Thank you for your understanding.

@the University of Valencia
Location
USA / Global
Work Mode
scholarship
Posted
3 days ago
Beware of scams! When applying for jobs, you should NEVER have to pay anything. Learn about job scams.
Join over 10,000 subscribers receiving our weekly newsletter.

2027: Applications Open for a Globally Recognized Learning Programme

Year PhD in Political Science — Study Inclusive Democracy in Brussels

2027 for Refugees and Asylum Seekers in Rwanda

Year Support to University of Toronto for International Students

Technical University of Munich: Research Integrated AI Systems for Scientific Discovery | Apply by August 10, 2026

Unknown